This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Methotrexate Injection, USP (2015-03-10)

Starting date:
March 10, 2015
Posting date:
March 16, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-52531

Recalled Product

Methotrexate Injection, USP

Reason

Visual inspection of retained samples of this lot has revealed presence of particluate matter.

Depth of distribution

Wholesalers and pharmacies

Affected products

Methotrexate Injection, USP

DIN, NPN, DIN-HIM
DIN 02417626
Dosage form

Solution

Strength

Methotrexate (Methotrexate sodium) 50 mg / 2 mL

Lot or serial number

7801370

Companies
Recalling Firm
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA
Marketing Authorization Holder
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA